Antimicrobial Resistance Practice Questions

Q: Antimicrobial resistance in frequent contact lens users is primarily due to which of the following?

Biofilm formation. **Explanation:** The primary mechanism behind antimicrobial resistance in frequent contact lens users is **Biofilm formation**. A biofilm is a structured community of microorganisms (such as *Pseudomonas aeruginosa* or *Staphylococcus aureus*) embedded within a self-produced matrix of extracellular polymeric substances (EPS) that adheres to the surface of the contact lens or the lens case. This matrix acts as a physical and chemical barrier, preventing antibiotics and disinfectants from penetrating and reaching the bacteria. Furthermore, bacteria within biofilms exhibit an altered phenotype with a slower metabolic rate, making them significantly less susceptible to drugs that target active cell division. **Analysis of Incorrect Options:** * **Options B and C (Improper handling/Unsanitary care):** These are major **risk factors** for introducing pathogens (like *Acanthamoeba*) and causing keratitis, but they describe the *source* of infection rather than the biological *mechanism* of drug resistance. * **Option D (Low potency):** Resistance is generally due to the protective environment of the biofilm or genetic mutations in the bacteria, not the inherent potency of the prescribed antibiotic class itself. **Clinical Pearls for NEET-PG:** * **Most common organism** in contact lens-related bacterial keratitis: *Pseudomonas aeruginosa*. * **Acanthamoeba Keratitis:** Characterized by a "ring-shaped infiltrate" and severe pain out of proportion to clinical signs; often associated with using tap water for lens cleaning. * **Management:** Contact lens wear must be discontinued immediately in any case of suspected microbial keratitis. * **Biofilm location:** Biofilms often form more extensively in the **contact lens case** than on the lens itself, emphasizing the need for regular case replacement.

Q: What is the most important mechanism of drug resistance development in tuberculosis?

Mutation. ### Explanation **Correct Answer: D. Mutation** **Why Mutation is Correct:** In *Mycobacterium tuberculosis* (MTB), drug resistance is almost exclusively due to **spontaneous, random genetic mutations** in the chromosomal genes. Unlike many other bacteria, MTB does not possess **plasmids** or transposons. Therefore, it cannot acquire resistance genes from other bacteria via horizontal gene transfer. When a patient is treated with inadequate monotherapy or irregular dosing, these rare, pre-existing resistant mutants are "selected" for survival while the sensitive bacilli are killed. This is known as **acquired resistance**. For example: * **katG gene mutation** leads to Isoniazid resistance. * **rpoB gene mutation** leads to Rifampicin resistance. **Why Other Options are Incorrect:** * **A, B, and C (Transduction, Conjugation, Transformation):** These are methods of **Horizontal Gene Transfer (HGT)**. * **Conjugation** (via plasmids) is the most common cause of multi-drug resistance in Gram-negative bacteria (e.g., *E. coli*). * **Transformation** involves the uptake of naked DNA (e.g., *S. pneumoniae*). * **Transduction** involves bacteriophages. * Since MTB lacks plasmids and does not participate in HGT, these mechanisms do not play a role in its clinical resistance. **Clinical Pearls for NEET-PG:** 1. **Multi-Drug Resistant TB (MDR-TB):** Defined as resistance to at least **Isoniazid (INH) and Rifampicin**. 2. **Extensively Drug-Resistant TB (XDR-TB):** MDR-TB plus resistance to any **fluoroquinolone** and at least one second-line injectable drug (now updated to include Bedaquiline or Linezolid in newer definitions). 3. **The "Fall and Rise" Phenomenon:** This occurs when a single effective drug is added to a failing regimen; the sensitive organisms die (fall), but the resistant mutants eventually multiply (rise). This is why TB must always be treated with a **combination** of drugs.

Q: A 60-year-old woman hospitalized for three weeks with widely metastatic ovarian adenocarcinoma becomes septic with vancomycin-resistant enterococcus. What is the mechanism of vancomycin resistance in this organism?

Formation of novel cell wall peptide bridges. **Explanation:** The correct answer is **D. Formation of novel cell wall peptide bridges.** **Mechanism of Resistance:** Vancomycin normally acts by binding to the **D-Ala-D-Ala** terminus of peptidoglycan precursors, preventing the transpeptidation and transglycosylation steps necessary for cell wall synthesis. In Vancomycin-Resistant Enterococci (VRE), the organism acquires genes (most commonly **VanA** or **VanB**) that alter this target. The terminal D-Alanine is replaced with **D-Lactate** (or occasionally D-Serine). This structural change results in the formation of novel peptide bridges (D-Ala-D-Lac) that have a significantly decreased affinity for vancomycin, allowing cell wall synthesis to continue despite the presence of the drug. **Analysis of Incorrect Options:** * **A. Acetylation of antibiotic:** This is a common mechanism for resistance against **Aminoglycosides** (via aminoglycoside-modifying enzymes). * **B. Altered drug-binding protein:** This refers to altered **Penicillin-Binding Proteins (PBPs)**, which is the mechanism for Methicillin-resistant *Staphylococcus aureus* (MRSA) and penicillin-resistant *Streptococcus pneumoniae*. * **C. Beta-lactamase production:** This is the mechanism used by many bacteria (e.g., *S. aureus*, *H. influenzae*) to hydrolyze the beta-lactam ring of penicillins and cephalosporins. **High-Yield NEET-PG Pearls:** * **VRE Risk Factors:** Prolonged hospitalization, ICU stay, and prior use of vancomycin or cephalosporins. * **Genetics:** The *VanA* gene is often carried on a **transposon (Tn1546)**, facilitating its spread. * **Treatment of Choice:** Linezolid, Quinupristin-Dalfopristin, or Tigecycline are typically used for VRE infections. * **D-Ala-D-Lac vs. D-Ala-D-Ser:** D-Ala-D-Lac provides high-level resistance (VanA, VanB), while D-Ala-D-Ser provides low-level resistance (VanC).

Q: XDR-TB is resistant to which of the following drug regimens?

Isoniazid, Rifampicin, Kanamycin, Ofloxacin. XDR-TB is resistant to which of the following drug regimens? **Explanation** Extensively Drug-Resistant Tuberculosis (XDR-TB) is a severe form of drug-resistant TB defined by specific resistance patterns to both first-line and second-line antitubercular drugs (ATDs) [1]. **1. Why Option C is Correct:** According to the WHO definition, XDR-TB is defined as TB that is resistant to: * **Isoniazid (H) and Rifampicin (R):** This baseline resistance defines Multidrug-Resistant TB (MDR-TB). * **Any Fluoroquinolone:** Such as Ofloxacin, Levofloxacin, or Moxifloxacin. * **At least one Second-line Injectable Drug:** Such as Kanamycin, Amikacin, or Capreomycin. Option C accurately reflects this combination (MDR + Fluoroquinolone + Injectable). **2. Analysis of Incorrect Options:** * **Option A:** This represents the standard first-line regimen (HRZE). Resistance to these defines "Poly-drug resistance" but not XDR. * **Option B:** While it includes resistance to H, R, and Kanamycin, it lacks resistance to a Fluoroquinolone, which is a mandatory criterion for XDR-TB. * **Option D:** Ethionamide is a second-line drug, but resistance to it (without an injectable or fluoroquinolone) does not meet the XDR criteria. **3. High-Yield Clinical Pearls for NEET-PG:** * **MDR-TB:** Resistance to at least Isoniazid and Rifampicin. * **Pre-XDR TB:** MDR-TB plus resistance to *either* a fluoroquinolone *or* a second-line injectable (but not both). * **New WHO Definition (2021 Update):** XDR-TB is now defined as MDR-TB plus resistance to any fluoroquinolone AND at least one additional Group A drug (Bedaquiline or Linezolid). *Note: For exam purposes, the classic definition (Option C) remains high-yield unless the "New WHO criteria" are specifically mentioned.* * **Treatment:** Bedaquiline-containing regimens (like BPaLM) are currently the preferred approach for resistant strains [1].

Q: Bacteria and fungi share some common mechanisms of resistance to antimicrobial drugs. However, bacteria possess a resistance mechanism that is not described in fungi. What is this mechanism?

Inactivation of drug. ### Explanation The correct answer is **C. Inactivation of drug.** #### 1. Why "Inactivation of drug" is correct In bacteria, enzymatic inactivation is a hallmark mechanism of resistance (e.g., **$\beta$-lactamases** hydrolyzing penicillins or **aminoglycoside-modifying enzymes**). In contrast, fungi primarily rely on structural alterations or transport mechanisms. While fungi can modify their metabolic pathways, they **do not possess enzymes** that chemically degrade or modify antifungal drugs (like Azoles, Amphotericin B, or Echinocandins) to render them inactive. #### 2. Analysis of Incorrect Options * **A. Alteration in the drug target:** This is common to both. Bacteria change Penicillin-Binding Proteins (PBPs), while fungi develop mutations in the **ERG11 gene** (altering the lanosterol 14-$\alpha$-demethylase enzyme) to resist azoles. * **B. Efflux of drug:** Both groups utilize ATP-binding cassette (ABC) transporters or Major Facilitator Superfamily (MFS) pumps to actively pump out drugs. In fungi, **CDR (Candida Drug Resistance)** and **MDR genes** are classic examples. * **D. Influx of drug:** Reduced permeability or decreased uptake is a shared mechanism. Bacteria may lose porin channels, while fungi (like *Cryptococcus*) can alter cell wall/membrane composition to limit the entry of drugs like Flucytosine. #### 3. NEET-PG High-Yield Pearls * **Most common mechanism of Azole resistance:** Efflux pumps and mutations in the *ERG11* gene. * **Flucytosine Resistance:** Occurs rapidly via mutations in **cytosine deaminase** (an example of target/pathway alteration, not inactivation). * **Amphotericin B Resistance:** Rare, but occurs via reduction in **Ergosterol** content in the fungal cell membrane. * **Echinocandin Resistance:** Associated with mutations in the **FKS1 gene** (target site alteration of $\beta$-1,3-D-glucan synthase).

Q: Which of the following statements regarding MRSA is true?

Pulsed-field gel electrophoresis is used for MRSA typing.. **Explanation:** **Correct Answer: D. Pulsed-field gel electrophoresis is used for MRSA typing.** Pulsed-field gel electrophoresis (PFGE) is considered the "gold standard" for the molecular typing and epidemiological investigation of MRSA outbreaks. It allows for the separation of large DNA fragments, creating a unique "fingerprint" that helps clinicians track the transmission of specific strains within a hospital or community. **Analysis of Incorrect Options:** * **Option A:** Ceftriaxone is a 3rd generation cephalosporin. MRSA is inherently resistant to almost all beta-lactams (including ceftriaxone). Vancomycin or Linezolid are preferred for systemic infections, while Mupirocin is used for superficial decolonization. * **Option B:** While many *S. aureus* strains produce beta-lactamase (penicillinase), the defining feature of MRSA is not enzyme production, but an **altered target site**. * **Option C:** The *mecA* gene indeed encodes for **PBP2a**; however, PBP2a has a **low affinity** for beta-lactam antibiotics. This low affinity prevents the antibiotic from binding to the bacterial cell wall, allowing peptidoglycan synthesis to continue despite the presence of the drug. **High-Yield Clinical Pearls for NEET-PG:** * **Screening:** Cefoxitin disk diffusion is the preferred method for detecting methicillin resistance in the lab (it is a better inducer of the *mecA* gene than oxacillin). * **Genetic Basis:** Resistance is carried on the **SCCmec** (Staphylococcal Cassette Chromosome mec) element. * **Exceptions:** The only beta-lactams with activity against MRSA are 5th generation cephalosporins (e.g., **Ceftaroline**, Ceftobiprole). * **DOC:** Vancomycin remains the drug of choice for serious MRSA infections.

Question 1

Antimicrobial resistance in frequent contact lens users is primarily due to which of the following?

Accepted Answer

Biofilm formation

Answer

Improper handling of lenses

Answer

Unsanitary lens care

Answer

Low potency of prescribed antibiotics

Question 2

Staphylococcus aureus causes a wide variety of infections, ranging from wound infections to pneumonia. What is the primary reason that treatment of S. aureus infections with penicillin is often complicated?

Accepted Answer

Production of penicillinase by S. aureus

Answer

Inability of penicillin to penetrate the cell membrane of S. aureus

Answer

Production of penicillin acetylase by S. aureus

Answer

Lack of penicillin binding sites on S. aureus

Question 3

What is the most important mechanism of drug resistance development in tuberculosis?

Accepted Answer

Mutation

Answer

Transduction

Answer

Conjugation

Answer

Transformation

Question 4

Which of the following statements are true regarding methicillin-resistant Staphylococcus aureus (MRSA)?

Accepted Answer

Isoxazolyl penicillin is highly effective

Answer

All MRSA are multidrug resistant

Answer

Vancomycin is effective

Answer

MRSA is more virulent than sensitive strains

Question 5

A 60-year-old woman hospitalized for three weeks with widely metastatic ovarian adenocarcinoma becomes septic with vancomycin-resistant enterococcus. What is the mechanism of vancomycin resistance in this organism?

Accepted Answer

Formation of novel cell wall peptide bridges

Answer

Acetylation of antibiotic

Answer

Altered drug-binding protein

Answer

Beta-lactamase production

Question 6

XDR-TB is resistant to which of the following drug regimens?

Accepted Answer

Isoniazid, Rifampicin, Kanamycin, Ofloxacin

Answer

Isoniazid, Rifampicin, Pyrazinamide, Ethambutol

Answer

Isoniazid, Rifampicin, Kanamycin, Pyrazinamide

Answer

Isoniazid, Rifampicin, Ethambutol, Ethionamide

Question 7

Bacteria and fungi share some common mechanisms of resistance to antimicrobial drugs. However, bacteria possess a resistance mechanism that is not described in fungi. What is this mechanism?

Accepted Answer

Inactivation of drug

Answer

Alteration in the drug target

Answer

Efflux of drug

Answer

Influx of drug

Question 8

Methicillin-resistant staphylococci do not respond to beta-lactam antibiotics because:

Accepted Answer

They have acquired penicillin-binding protein which has low affinity for beta-lactam antibiotics.

Answer

They produce a beta-lactamase which destroys methicillin and related drugs.

Answer

They elaborate an amidase which destroys methicillin and related drugs.

Answer

They are less permeable to beta-lactam antibiotics.

Question 9

Which of the following statements regarding MRSA is true?

Accepted Answer

Pulsed-field gel electrophoresis is used for MRSA typing.

Answer

Ceftriaxone is preferred for the treatment of superficial MRSA infections.

Answer

MRSA isolates produce beta-lactamase.

Answer

The mecA gene of MRSA encodes for penicillin-binding protein 2a (PBP2a), which has a high affinity for beta-lactam antibiotics.

Question 10

Which of the following is NOT a bacterial drug resistance mechanism?

Accepted Answer

Inhibition of DNA gyrase or topoisomerase activity by the bacteria.

Answer

Synthesis of enzymes that inactivate antibiotics.

Answer

Alteration of porin channels to reduce drug entry.

Answer

Active efflux of the drug out of the bacterial cell.

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?